Alzheimer Society of Nova Scotia
Have you been diagnosed with dementia? Do you have a friend or family member that has been diagnosed with dementia? Are you worried you, or someone you know, may have dementia? The Alzheimer’s Society of Nova Scotia is there to help. Please visit https://alzheimer.ca/ns/en or call 1-800-611-6345 for more information on the support programs and services they have to offer.
Caregivers Nova Scotia
At Caregivers Nova Scotia, we’re focused on empowering caregivers, supporting their efforts, and recognizing the invaluable contribution they make both to those in need and to society in general. We do this through programs, support groups, advocacy, and services all geared toward the unique needs of friends and family giving care.
We are here to help in every way we can, from providing information, having someone to talk to on the phone, and offering support groups. Contact us toll-free at 1.877.488.7390 or via email at info@CaregiversNS.org
If you are between 50 and 90 years old and interested in learning about your risk for Alzheimer’s Disease you may qualify for a no cost DNA test.
Dr. Johnston appears on The Rick Howe Show
(January 22, 2020)
Aducanumab for treatment of Alzheimer’s disease
For the first time in almost 18 years, the U.S. Food and Drug Administration (FDA) has approved a new treatment — Aduhelm, also known as aducanumab — for Alzheimer’s disease. Centricity Research is proud to be a part of the global team that worked on the corresponding clinical trial. Thank you to everyone who participated in this trial at our sites!
Local clinical research company at forefront of Alzheimer’s studies
Important, cutting-edge clinical trial research related to Alzheimer’s disease and dementia is happening right here in Nova Scotia. Since 2006, Centricity Research has been actively working toward better treatments for people with dementia, including Alzheimer’s Disease. With the help of local Alzheimer’s patients, their discoveries are contributing to research that has the potential to improve the lives of people around the world. Read more…
Free memory testing available to Nova Scotians across the province
Alzheimer’s and dementia are devastating diseases that affect more than 14,000 Nova Scotians. It is estimated that 937,000 Canadians will be living with dementia in 15 years.
Alzheimer’s and dementia are devastating diseases that affect more than 14,000 Nova Scotians. It is estimated that 937,000 Canadians will be living with dementia in 15 years. Centricity Research in Halifax offers free memory testing to help residents stay on top of their memory health. Read More…
Local research group recruiting volunteers to help further Alzheimer’s treatments
Genetic testing is often used in medical research to help researchers understand how different combinations of genes may or may not contribute to a wide variety of diseases.
Nova Scotia’s Centricity Research collects important DNA samples from volunteers to identify and create a registry of populations who are most susceptible to Alzheimer’s disease. With this information, the organization develops a database so that people who carry certain genes might be contacted in the future if a research opportunity specific to their genetic make-up becomes available. With this information, new and improved treatments could be realized and enhance the lives of those living with Alzheimer’s. Read More…
Local Clinical Research Sites Searching for Participants for Alzheimer’s Research
Nova Scotia’s Centricity Research is actively recruiting volunteers for an innovative clinical drug trial
Centricity Research is working with Alzheon, a clinical-stage biopharmaceutical company, to help with important research that aims to improve the lives of people living with Alzheimer’s disease. They are actively seeking volunteers for a Phase 3 trial called APOLLOE4 that evaluates the effectiveness and safety of a new investigational drug formulated for people who have a specific genotype. Read More…
Local Research Company Contributes to Exciting New Alzheimer’s Drug
An innovative new drug that treats Alzheimer’s disease was approved for use in the United States by the US Food and Drug Administration (FDA). The drug, called aducanumab, is the first new clinical treatment to enter the market in 20 years and Nova Scotia’s own Centricity Research helped with the research leading up to its approval.
Centricity Research is involved in a variety of clinical research trials that help to develop treatment options and advances in healthcare for individuals living with Alzheimer’s disease. They have been working with Biogen, the company that discovered aducanumab, to study the efficacy and safety of the drug. Read More…
Mobile memory clinics serve residents for free in their own communities
Centricity Research serves communities within a two-hour drive of Halifax or New Minas
Standardized memory tests taken over time allow people to have their memory assessed and tracked in order to have a baseline to compare future memory tests to.
Annual testing helps individuals to discover possible memory loss at its earliest stages. Just like people keep track of other health measurements, memory can also be checked periodically.
“At a certain age, people automatically start checking their blood pressure, have breast and prostate exams, and start to collect routine blood work to check for certain deficiencies that are common with aging,” explains Nicole Blanchard, Director of Operations forCentricity Research. “Memory testing can be included in this list as some memory loss with age is normal, but anything more than that can be detected by having your memory tested annually.”…Read More…
New Research studies link between gut bacteria and Alzheimer’s disease
Centricity Research is actively looking for participants for a new phase 3 clinical trial.
Nova Scotia’s Centricity Research is currently involved in a research study that hopes to treat mild to moderate Alzheimer’s Disease more effectively.
Centricity Research, a clinical research and memory facility based in Halifax and New Minas, is working with Shanghai Green Valley Pharmaceutical Co. LTD to test the safety and effectiveness of a medication called Green Memory (GV-971). This is a phase 3 clinical trial, which means the medication has successfully moved through two phases of research study….Read More…